MPM Oncology Impact Management »

Lantheus Holdings Inc Common Stock Usd 0.01 shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Lantheus Holdings Inc Common Stock Usd 0.01

Tip: Access up to 7 years of quarterly data

All positions including Lantheus Holdings Inc Common Stock Usd 0.01 held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lantheus Holdings Inc Common Stock Usd 0.01 by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $12M 150k 80.29

More positions owned by MPM Oncology Impact Management

Cullinan Therapeutics Common (CGEM)
Insmed Incorporated Common (INSM)
Olema Pharmaceuticals Common (OLMA)
iTeos Therapeutics Common (ITOS)
Crinetics Pharmaceuticals Common (CRNX)
Madrigal Pharmaceuticals Common (MDGL)
Iovance Biotherapeutics Common (IOVA)
Natera Common (NTRA)
Mirum Pharmaceuticals Common (MIRM)
Ultragenyx Pharmaceutical Common (RARE)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Guardant Health Common (GH)
Disc Medicine Common (IRON)
Alkermes Common (ALKS)
Edgewise Therapeutics Common (EWTX)

View all positions for MPM Oncology Impact Management

Top funds holding Lantheus Holdings Inc Common Stock Usd 0.01

BlackRock
Vanguard Group
Henderson Group
State Street Corporation
Farallon Capital Management
Invesco
Geode Capital Management
Westfield Capital Management Company
Macquarie Group
Reinhart Mahoney Capital Management
T. Rowe Price Associates
Dimensional Fund Advisors
Millennium Management
Silvercrest Asset Management Group
Charles Schwab Investment Management

View all funds holding Lantheus Holdings Inc Common Stock Usd 0.01